ALTU-139

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameALTU-139
Drug Alias NameALTU-139
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLipase stimulants
TargetsLipase
Therapy Area/IndicationsMalabsorption Syndromes
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAjinomoto Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAjinomoto Co Inc
Active IndicationsN/A
Inactive IndicationsMalabsorption Syndromes

Other Information

ATC CodeN/A
Related LinksN/A